IASLC WCLC 2021: Adjuvant Bevacizumab May Reduce Brain Metastases in Resected Non–Small Cell Lung Cancer
But no benefits were evident in terms of extracranial recurrence or survival
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.